Mr. Welfare et al., Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: lack of a polymorphism in CYP1A2 in Caucasians, PHARMACOGEN, 9(3), 1999, pp. 367-375
The cytochrome P450 CYP1A2 is important in the metabolism of both drugs and
procarcinogens such as heterocyclic amines. We aimed to clarify the existe
nce of a phenotypic polymorphism and explore the molecular basis of such a
polymorphism. Ninety-two non-smoking individuals underwent caffeine phenoty
ping, The distribution of the 1,7-dimethylxanthine + 1,7-dimethyluracil/caf
feine (17U + 17X/137X) ratio and log-transformed data were determined, Prob
it plots were constructed and the distribution fitted using maximum likelih
ood method. The CYP1A2 gene, including upstream regulatory regions, was exa
mined for sequence polymorphisms using the single-strand conformation polym
orphism technique in 19 individuals and by complete DNA sequencing in two i
ndividuals from the extremes of the distribution, We found a similar range
(1.45-18.65) and median (6.7) for the 17U + 17X/137X ratio to that found in
previous studies of non-smoking Caucasians and no effect of sex, The 17U 17X/137X ratio gave a normal distribution when log-transformed, Maximum li
kelihood analysis showed that the log-normal and bimodal distributions had
similar deviances but the log-normal distribution was favoured because it h
as fewer parameters, There was no evidence for significant DNA sequence dif
ferences between fast and slow metabolizers, although some differences from
published sequences including a silent polymorphism in exon 7 which were u
nlikely to be of functional significance were found. We therefore conclude
that CYP1A2 does not show functionally significant polymorphism but that th
e wide interindividual variation in activity may be due to environmental fa
ctors. Pharmacogenetics 9:367-375 (C) 1999 Lippincott Williams & Wilkins.